Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

A major new study found the risk of death or the cancer recurring dropped significantly in people who took on exercise ...

Patients who have been treated for colon cancer could cut their risk of death by 37% if they stick to a structured exercise ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Results from the Phase Ib/II CARTITUDE-1 trial demonstrated that a single infusion of Carvykti delivered durable, ...

Google says AI is helping fight cancer by improving early detection, diagnosis, and research. Tools like AlphaFold and AI ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a ...